BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  PENTAX Medical Names Veteran Executive as The Americas Region President and CEO

  PENTAX Medical announced that David Woods, the current Global CMO of PENTAX Medical, has been appointed President of PENTAX Medical of the Americas, effective immediately.

  December 21, 2017

   · 

  2 min read
• ATRP Solutions Renamed Pilot Polymer Technologies

  The new name better reflects PPT’s broadening proprietary technologies in important chemical markets.

  December 21, 2017

   · 

  2 min read
• 

  Business

  TRACON Pharma, Ambrx Ink Deal Up to $143.5M for TRC105

  TRACON will receive an upfront payment of $3M, and is eligible to receive development and regulatory milestones of up to $10.5M, and commercial sales milestones of up to $130M.

  December 21, 2017

   · 

  5 min read
• 

  Business

  Zomedica, Celsee Ink Deal For Cancer Liquid Biopsy Platform

  Zomedica today announced it has entered into a license and supply agreement with Celsee.

  December 21, 2017

   · 

  8 min read
• Business

  Jacobson Pharma Enters Agreements With Henlius Biotech Inc. to Tap Biologics Market

  Under the licensing Framework Agreement, Jacobson Medical will be granted an exclusive right to develop and market a propriety biosimilar product of Shanghai Henlius in Hong Kong and Macau for a period of 10 years

  December 21, 2017

   · 

  4 min read
• Drug Development

  FDA Grants RMAT Designation For Mesoblast’s Cell Therapy in Heart Failure Patients With LVADs

  The RMAT designation under the 21st Century Cures Act aims to expedite the development of regenerative medicine therapies intended for the treatment of serious diseases and life-threatening conditions.

  December 21, 2017

   · 

  8 min read
• Drug Development

  CANbridge Life Sciences Submits Investigational NDA for CAN017 Trial in Esophageal Squamous Cell Cancer (ESCC) in China

  CANBridge Life Sciences announced that it has submitted an IND application to the CFDA for a Phase Ib/III clinical study of CAN017 in ESCC.

  December 21, 2017

   · 

  4 min read
• 

  Policy

  Gynesonics Announces Submission of FDA 510k for Incision-Free Treatment of Symptomatic Uterine Fibroids

  The Sonata System is designed to treat fibroids transcervically with radiofrequency energy guided by an integrated intrauterine ultrasound probe.

  December 21, 2017

   · 

  2 min read
• Nemaura Announces Completion of SugarBEAT European Clinical Trial Programme and Positive Interim Results

  Nemaura announced the completion of its sugarBEAT European clinical trial programme and positive interim accuracy data.

  December 21, 2017

   · 

  3 min read
• Business

  Aetna Joins SAFE-BioPharma Association

  It is the first health care benefits company to join the association.

  December 21, 2017

   · 

  2 min read